Among other risks factors for urinary incontinence (UI) is the use of antihypertensive medicines. This paper aimed to value the prevalence of urinary incontinence in menopausal women attending in the Family Health Strategy in Bozano/RS and to assess the risk of these medicine use. It is a descriptive, cross-sectional and analytical study with a comparison group, being group 1 (G1) formed by women who use anti-hypertensive medicines and have a body mass index (BMI) <29,9 kg/m², and group 2 (G2) by women with BMI <29,9 kg/m² and no use of anti-hypertensive medicines. The sampling is composed of 70 women, 21 in G1 group and 49 in G2 group. Data collection was a questionnaire addressing issues related to domestic preconditions for women's health, medicine use and uro-gynecological conditions. As for the prevalence of UI, 52.8% had this complaint (21.4% in G1 and 31.4% in G2). Concerning the pharmacological class of anti-hypertensive medicines, angiotensin-conversing enzyme inhibitors are used by 33.3% of women. As for the risk for UI using anti-hypertensive medicines, the odds ratio showed that women who use this medicine are 3.06 times more likely to be incontinent (p = 0,03). The results suggest that the use of antihypertensive medicines is a predictor of UI in the group of women studied.
Urinary incontinence; Menopause; Anti-hypertensive medicines; Ginecology; Health of the Elderly; Aged
